Beam Therapeutics Inc. (BEAM) Total liabilities 2019–2025
Beam Therapeutics Inc. (BEAM) total liabilities at each fiscal year-end, per SEC filings.
$242.8MFY2025 · since FY2019: $55.2M → $242.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $242.8M | -34.4% |
| FY2024 | $370.3M | -22.6% |
| FY2023 | $478.4M | -21.3% |
| FY2022 | $608.2M | -6.1% |
| FY2021 | $647.7M | +214.2% |
| FY2020 | $206.1M | +273.7% |
| FY2019 | $55.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice